The somatostatin analogs market is expected to grow from USD 6,780 million in 2022 to USD 15,357.75 million by 2032, at a CAGR of 8.52% during the forecast period 2023-2032.
Somatostatin analogs are the synthetic version of somatostatin. Somatostatin plays a regulatory role in various physiological processes, including inhibiting the secretion of several other hormones. Somatostatin analogs are primarily used to treat hormonal disorders. Somatostatin analogs are administered by injection. The common side effects of somatostatin analogs may include injection site reactions, gastrointestinal disturbances such as diarrhoea and abnormalities in liver function.
The increasing prevalence of hormonal disorders is one of the major factors driving the Somatostatin Analogs market. Increasing diagnosis has led to early detection, which increased the need for Somatostatin Analogs. In addition, growing awareness among healthcare professionals and patients also increases the demand for Somatostatin Analogs market. However, the high cost of treatment will hamper the market's growth. Additionally, the growing healthcare infrastructure will boost the growth of the Somatostatin Analogs market during the forecast period.
This study comprehensively analyses type, application, end user and region. The type segment includes octreotide, lanreotide and pasireotide. The octreotide segment registered the largest market share in 2022. The octreotide is utilized in various therapeutic applications. The application segment comprises acromegaly, neuroendocrine tumors (NETs) and others. The acromegaly segment held the largest market share in 2022. The presence of several treatments for acromegaly and awareness about acromegaly are the main factors which contribute to the growth of the segment. The end user segment is classified into hospital and pharmaceutical companies. The hospital segment generated the highest market revenue in 2022. The rise in the number of diagnosis and the increasing number of hospital admissions are the factors driving the segment's growth.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The North American region held the highest market revenue in 2022. It is mainly due to rising cases of neuroendocrine tumors and acromegaly. Also, rising awareness among the individual will boost the region's market growth. The presence of key players in the region will also boost the market’s growth. Asia Pacific region is anticipated to grow fastest over the forecast period. Growing population, technological advancement, and increasing healthcare infrastructure will likely drive the region's growth.
Some of the notable players in the market are Amryt Pharma plc, Camurus AB, Crinetics Pharmaceuticals, Ipsen Pharma, Novartis AG, Peptron Inc, Recordati Rare Diseases, Sun Pharmaceutical Industries Ltd and Teva Pharmaceuticals Inc among others.
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Type
4.3.2. Market Attractiveness Analysis by Application
4.3.3. Market Attractiveness Analysis by End User
4.3.4. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing Prevalence of Hormonal Disorders
5.2.2. Increasing Awareness and Diagnosis
5.3. Restraints
5.3.1. High Cost of Treatment
5.4. Opportunities
5.4.1. Growing healthcare infrastructure
5.5. Challenges
5.5.1. Regulatory Hurdles
6. Global Somatostatin Analogs Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Octreotide
6.3. Lanreotide
6.4. Pasireotide
7. Global Somatostatin Analogs Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. Acromegaly
7.3. Neuroendocrine Tumors (NETs)
7.4. Others
8. Global Somatostatin Analogs Market Analysis and Forecast, By End User
8.1. Segment Overview
8.2. Hospital
8.3. Pharmaceutical Companies
9. Global Somatostatin Analogs Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Somatostatin Analogs Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in the Somatostatin Analogs Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. Amryt Pharma plc
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Camurus AB
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. Crinetics Pharmaceuticals
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Ipsen Pharma
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Novartis AG
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. Peptron Inc
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Peptron Inc
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. Sun Pharmaceutical Industries Ltd
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Teva Pharmaceuticals Inc
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
List of Table
1. Global Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
2. Global Octreotide, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)
3. Global Octreotide, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)
4. Global Pasireotide, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)
5. Global Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
6. Global Acromegaly, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)
7. Global Neuroendocrine Tumors (NETs), Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)
8. Global Others, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)
9. Global Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
10. Global Hospital, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)
11. Global Pharmaceutical Companies, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)
12. Global Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)
13. North America Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
14. North America Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
15. North America Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
16. U.S. Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
17. U.S. Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
18. U.S. Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
19. Canada Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
20. Canada Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
21. Canada Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
22. Mexico Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
23. Mexico Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
24. Mexico Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
25. Europe Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
26. Europe Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
27. Europe Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
28. Germany Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
29. Germany Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
30. Germany Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
31. France Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
32. France Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
33. France Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
34. U.K. Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
35. U.K. Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
36. U.K. Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
37. Italy Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
38. Italy Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
39. Italy Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
40. Spain Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
41. Spain Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
42. Spain Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
43. Asia Pacific Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
44. Asia Pacific Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
45. Asia Pacific Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
46. Japan Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
47. Japan Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
48. Japan Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
49. China Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
50. China Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
51. China Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
52. India Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
53. India Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
54. India Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
55. South America Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
56. South America Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
57. South America Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
58. Brazil Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
59. Brazil Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
60. Brazil Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
61. Middle East and Africa Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
62. Middle East and Africa Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
63. Middle East and Africa Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
64. UAE Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
65. UAE Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
66. UAE Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
67. South Africa Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)
68. South Africa Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)
69. South Africa Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)
List of Figures
1. Global Somatostatin Analogs Market Segmentation
2. Somatostatin Analogs Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Somatostatin Analogs Market Attractiveness Analysis by Type
9. Global Somatostatin Analogs Market Attractiveness Analysis by Application
10. Global Somatostatin Analogs Market Attractiveness Analysis by End User
11. Global Somatostatin Analogs Market Attractiveness Analysis by Region
12. Global Somatostatin Analogs Market: Dynamics
13. Global Somatostatin Analogs Market Share by Type (2023 & 2032)
14. Global Somatostatin Analogs Market Share by Application (2023 & 2032)
15. Global Somatostatin Analogs Market Share by End User (2023 & 2032)
16. Global Somatostatin Analogs Market Share by Regions (2023 & 2032)
17. Global Somatostatin Analogs Market Share by Company (2022)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.